Shalby Ltd

Shalby Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shalby Ltd

₹ 222 -1.83%
23 Dec - close price
shalby.org BSE: 540797 NSE: SHALBY
About

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]
The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.

Key Points

Hospitals Portfolio
The co. operates 14 hospitals across India with a total bed capacity of 2,000+ beds. It also owns 60 outpatient clinics across 16 states in India and 5 OP clinics in African Countries. [1] [2] The co. has two upcoming facilities with a combined capacity of 321 beds will be located in Maharashtra. [3]

Website BSE NSE
  • Market Cap ₹ 2,393 Cr.
  • Current Price ₹ 222
  • High / Low ₹ 340 / 204
  • Stock P/E 45.8
  • Book Value ₹ 93.2
  • Dividend Yield 0.54 %
  • ROCE 11.0 %
  • ROE 8.16 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 20.0% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 18.1%

Cons

  • Company has a low return on equity of 7.39% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Allcap BSE SmallCap BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
181.62 162.37 162.57 201.68 201.80 202.46 198.98 235.49 237.98 216.05 244.23 278.89 267.54
152.18 134.17 138.57 161.62 164.73 168.65 173.32 192.36 185.26 173.73 205.37 233.68 234.89
Operating Profit 29.44 28.20 24.00 40.06 37.07 33.81 25.66 43.13 52.72 42.32 38.86 45.21 32.65
OPM % 16.21% 17.37% 14.76% 19.86% 18.37% 16.70% 12.90% 18.32% 22.15% 19.59% 15.91% 16.21% 12.20%
2.82 -1.62 4.27 3.99 5.31 4.19 9.18 4.53 5.38 4.52 4.99 9.70 7.16
Interest 1.60 1.56 1.74 1.84 1.79 2.67 2.84 2.75 3.17 3.63 6.47 8.12 9.26
Depreciation 11.48 11.26 11.15 11.58 11.90 11.79 12.81 11.94 12.30 12.40 15.60 16.37 16.84
Profit before tax 19.18 13.76 15.38 30.63 28.69 23.54 19.19 32.97 42.63 30.81 21.78 30.42 13.71
Tax % 44.00% 6.18% 34.20% 34.38% 35.83% 35.09% 27.57% 36.85% 35.30% 38.14% 26.35% 51.55% 82.71%
10.75 12.91 10.13 20.11 18.40 15.28 13.90 20.82 27.57 19.06 16.04 14.74 2.36
EPS in Rs 1.00 1.20 0.95 1.86 1.70 1.42 1.29 1.93 2.55 1.77 1.54 1.45 0.31
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
259 275 290 324 378 462 487 431 699 805 934 1,007
196 207 235 252 299 379 404 342 577 667 755 848
Operating Profit 63 68 56 71 79 83 83 89 122 138 179 159
OPM % 24% 25% 19% 22% 21% 18% 17% 21% 17% 17% 19% 16%
2 2 2 7 10 9 17 8 8 22 19 26
Interest 2 5 10 11 12 9 7 5 8 11 18 27
Depreciation 11 21 11 17 23 33 36 37 43 48 52 61
Profit before tax 52 43 36 50 54 50 57 55 79 102 128 97
Tax % 28% 43% -1% 43% 27% 37% 51% 23% 32% 34% 35%
38 25 36 29 39 32 28 42 54 68 84 52
EPS in Rs 11.17 7.36 4.30 3.40 3.65 2.93 2.55 3.93 5.01 6.27 7.78 5.07
Dividend Payout % 0% 0% 0% 0% 0% 17% 20% 25% 20% 19% 15%
Compounded Sales Growth
10 Years: 14%
5 Years: 15%
3 Years: 29%
TTM: 15%
Compounded Profit Growth
10 Years: 8%
5 Years: 20%
3 Years: 22%
TTM: -33%
Stock Price CAGR
10 Years: %
5 Years: 19%
3 Years: 18%
1 Year: -28%
Return on Equity
10 Years: 7%
5 Years: 6%
3 Years: 7%
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 35 35 87 87 108 108 108 108 108 107 107 107
Reserves 106 133 117 164 643 672 691 727 768 820 893 899
37 98 224 328 114 71 62 44 155 180 378 463
39 85 75 99 96 89 105 118 162 173 231 247
Total Liabilities 217 351 504 679 961 939 967 997 1,194 1,281 1,609 1,717
130 175 319 323 650 692 672 660 675 685 966 971
CWIP 5 91 82 221 47 3 6 8 6 11 15 11
Investments 0 0 0 0 0 11 28 16 25 146 81 112
81 85 102 134 264 233 260 314 488 440 547 623
Total Assets 217 351 504 679 961 939 967 997 1,194 1,281 1,609 1,717

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
60 14 43 55 79 19 68 20
-153 -236 1 -31 -51 -60 -61 146
96 222 -51 -22 -30 90 -50 -151
Net Cash Flow 3 0 -6 3 -2 49 -43 15

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 21 29 40 38 49 64 71 80 53 48 57
Inventory Days 77 113 119 105 242 1,152 1,361
Days Payable 395 462 522 415 606 546 744
Cash Conversion Cycle 21 29 40 -280 -299 -339 -239 -283 53 654 673
Working Capital Days 35 -46 -26 -34 -3 57 70 84 109 111 107
ROCE % 22% 13% 12% 9% 7% 7% 7% 10% 10% 11%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
74.02% 74.02% 74.04% 74.04% 74.12% 74.12% 74.12% 74.12% 74.12% 74.24% 74.25% 74.25%
3.83% 3.95% 3.92% 3.78% 3.97% 3.92% 4.00% 4.11% 4.62% 4.88% 5.35% 5.37%
0.00% 0.00% 0.00% 0.28% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.09%
21.22% 21.10% 21.12% 20.97% 20.97% 21.09% 21.00% 20.90% 20.42% 20.13% 19.65% 19.59%
0.93% 0.93% 0.93% 0.93% 0.87% 0.87% 0.87% 0.87% 0.83% 0.76% 0.70% 0.69%
No. of Shareholders 55,56255,23354,66654,53752,77552,18152,58050,22549,49549,85849,31551,479

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls